Publications by authors named "M Brahimi"

Article Synopsis
  • Bluetongue (BT) is a viral disease affecting various ruminants across Africa, but data on its prevalence is limited, prompting a systematic review and meta-analysis.
  • The study found a pooled seroprevalence of the bluetongue virus (BTV) to be 45.02%, with higher rates seen in cattle (49.70%) and goats (47.00%), particularly in the southeastern region of Africa.
  • It was noted that female animals showed a significantly higher seroprevalence (53.30%) compared to males (28.10%), highlighting the need for ongoing monitoring and surveillance to prevent the disease's spread.
View Article and Find Full Text PDF

Background: Acute leukemia (AL) constitutes a group of malignant hematological diseases with multifactor origins. Some human leukocyte alleles (HLA) may be important genetic risk factors for development of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is still unknown whether there is a relationship between ALL and AML with some alleles of the major histocompatibility complex.

View Article and Find Full Text PDF

The antitumoral contribution of γδT cells depends on their activation and differentiation into effectors. This depends on different molecules and membrane receptors, which conditions their physiology. This study aimed to determine the phenotypic characteristics of γδT cells in glioblastoma (GBM) according to five layers of membrane receptors.

View Article and Find Full Text PDF

Gliomas are histologically defined as low-grade gliomas (LGG) and high-grade gliomas (HGG). The most common type of HGG is the glioblastoma (GBM). We aimed to determine the immunological characteristics of CD3 T-cells, Vδ1 T-cells, and microglia/macrophages infiltrating brain gliomas.

View Article and Find Full Text PDF

Introduction: The storage of harvested stem cells, in standard refrigerators at +4°C, is a simple and inexpensive alternative to cryopreservation for most patients living in countries with limited resources. We present the 10 years' experience of our single center from Oran in Algeria using non-cryopreserved stem cells after conditioning with high dose chemotherapy, in a large group of myeloma and lymphoma patients.

Methods: From May 2009 to December 2019, autologous stem cell transplantation (ASCT) was carried out in our center, of which 420 with multiple myeloma (MM) and 154 patients with lymphoma.

View Article and Find Full Text PDF